Post by Bristol Myers Squibb on X
Bristol Myers Squibb@bmsnews
X#MEDIA: @US_FDA granted accelerated approval to our new CELMoD treatment for relapsed or refractory #MultipleMyeloma in adults, introducing a new class of treatment. t.co
26 likes4 repliesPosted Aug 13, 2026